| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/BMT.2014.64 |
| P698 | PubMed publication ID | 24710564 |
| P50 | author | Sebastian Giebel | Q92489652 |
| Nicolaas Schaap | Q57161901 | ||
| Michel Attal | Q57306384 | ||
| Hendrik Veelken | Q30513581 | ||
| P2093 | author name string | R Foa | |
| M Labopin | |||
| M Mohty | |||
| M Michallet | |||
| D Blaise | |||
| C Bonmati | |||
| N-C Gorin | |||
| T Czerw | |||
| P-Y Dumas | |||
| P2860 | cites work | G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial | Q74053100 |
| High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome | Q78800310 | ||
| Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation | Q79370344 | ||
| Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission | Q45308137 | ||
| Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia | Q47929864 | ||
| Gene-marking to trace origin of relapse after autologous bone-marrow transplantation | Q49158499 | ||
| Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial. | Q50783861 | ||
| Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial | Q51549878 | ||
| The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia | Q68820489 | ||
| The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia | Q73516117 | ||
| Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia | Q24234458 | ||
| The EBMT activity survey: 1990-2010 | Q28265604 | ||
| G-CSF and its receptor in myeloid malignancy | Q28276273 | ||
| Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse | Q28280300 | ||
| A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031). | Q33502338 | ||
| Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 | ||
| High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. | Q34297698 | ||
| Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study | Q34521035 | ||
| 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline | Q34523108 | ||
| A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group | Q34743741 | ||
| Hematopoietic growth factors and their receptors in acute leukemia | Q36775150 | ||
| Acute myeloid leukemia and the position of autologous stem cell transplantation | Q36981927 | ||
| Is there a role for autotransplants in AML in first remission? | Q37369377 | ||
| Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. | Q40287284 | ||
| Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies | Q40531685 | ||
| Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies | Q40697302 | ||
| Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaem | Q43573116 | ||
| Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group | Q44221131 | ||
| P433 | issue | 7 | |
| P921 | main subject | acute leukemia | Q976388 |
| P304 | page(s) | 950-954 | |
| P577 | publication date | 2014-04-07 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT | |
| P478 | volume | 49 |
| Q38568355 | Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects |
| Q40831363 | Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood an |
| Q42711146 | Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation |
Search more.